Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kitchen, PRB; Smith, HJ; Henderson, MA; Goldhirsch, A; Castiglione-Gertsch, M; Coates, AS; Gusterson, B; Brown, RW; Gelber, RD; Collins, JP
   Tubular carcinoma of the breast: Prognosis and response to adjuvant systemic therapy
   ANZ journal of surgery
   
   P.R.B. Kitchen et al., "Tubular carcinoma of the breast: Prognosis and response to adjuvant systemic therapy", AUST NZ J S, 71(1), 2001, pp. 27-31
2. Colleoni, M; Gelber, RD; Gelber, S; Castiglione-Gertsch, M; Coates, AS; Goldhirsch, A
   How to improve timing and duration of adjuvant chemotherapy
   BREAST
   
   M. Colleoni et al., "How to improve timing and duration of adjuvant chemotherapy", BREAST, 10, 2001, pp. 101-105
3. Thurlimann, B; Price, KN; Castiglione, M; Coates, AS; Goldhirsch, A; Gelber, RD; Forbes, J; Holmberg, S; Veronesi, A; Bernhard, J; Zahrieh, D
   Randomized controlled trial of ovarian function suppression plus tamoxifenversus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93
   BREAST
   
   B. Thurlimann et al., "Randomized controlled trial of ovarian function suppression plus tamoxifenversus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93", BREAST, 10, 2001, pp. 130-138
4. Bonetti, M; Gelber, RD; Goldhirsch, A; Castiglione-Gertsch, M; Coates, AS
   Features that predict responsiveness to chemotherapy and endocrine therapies
   BREAST
   
   M. Bonetti et al., "Features that predict responsiveness to chemotherapy and endocrine therapies", BREAST, 10, 2001, pp. 147-157
5. Coates, AS; Hurny, C; Peterson, HF; Bernhard, J; Castiglione-Gertsch, M; Gelber, RD; Goldhirsch, A
   Quality of life scores predict outcome in metastatic but not in early breast cancer
   BREAST
   
   A.S. Coates et al., "Quality of life scores predict outcome in metastatic but not in early breast cancer", BREAST, 10, 2001, pp. 164-170
6. Butow, PN; Brown, JE; Coates, AS; Dunn, SM
   Psychosocial predictors of outcome IV: patients with early-stage breast cancer
   BREAST
   
   P.N. Butow et al., "Psychosocial predictors of outcome IV: patients with early-stage breast cancer", BREAST, 10, 2001, pp. 182-189
7. Gelber, S; Coates, AS; Goldhirsch, A; Castiglione-Gertsch, M; Marini, G; Lindtner, J; Edelmann, DZ; Gudgeon, A; Harvey, V; Gelber, RD
   Effect of pregnancy on overall survival after the diagnosis of early-stagebreast cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   S. Gelber et al., "Effect of pregnancy on overall survival after the diagnosis of early-stagebreast cancer", J CL ONCOL, 19(6), 2001, pp. 1671-1675
8. Colleoni, M; Gelber, S; Coates, AS; Castiglione-Gertsch, M; Gelber, RD; Price, K; Rudenstam, CM; Lindtner, J; Collins, J; Thurlimann, B; Holmberg, SB; Cortes-Funes, H; Simoncini, E; Murray, E; Fey, M; Goldhirsch, A
   Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   M. Colleoni et al., "Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer", J CL ONCOL, 19(21), 2001, pp. 4141-4149
9. Goldhirsch, A; Glick, JH; Gelber, RD; Coates, AS; Senn, HJ
   Meeting highlights: International consensus panel on the treatment of primary breast cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   A. Goldhirsch et al., "Meeting highlights: International consensus panel on the treatment of primary breast cancer", J CL ONCOL, 19(18), 2001, pp. 3817-3827
10. Gelber, S; Gelber, RD; Coates, AS; Goldhrisch, A; Castiglione-Gertsch, M
    Too early to say that pregnancy has an antitumor effect on breast cancer -In reply
    JOURNAL OF CLINICAL ONCOLOGY
    
    S. Gelber et al., "Too early to say that pregnancy has an antitumor effect on breast cancer -In reply", J CL ONCOL, 19(16), 2001, pp. 3708-3708
11. Cole, BF; Gelber, RD; Gelber, S; Coates, AS; Goldhirsch, A
    Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis
    LANCET
    
    B.F. Cole et al., "Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis", LANCET, 358(9278), 2001, pp. 277-286
12. Bernhard, J; Sullivan, M; Hurny, C; Coates, AS; Rudenstam, CM
    Clinical relevance of single item quality of life indicators in cancer clinical trials
    BRITISH JOURNAL OF CANCER
    
    J. Bernhard et al., "Clinical relevance of single item quality of life indicators in cancer clinical trials", BR J CANC, 84(9), 2001, pp. 1156-1165
13. Brown, JE; Brown, RF; Miller, RM; Dunn, SM; King, MT; Coates, AS; Butow, PN
    Coping with metastatic melanoma: The last year of life
    PSYCHO-ONCOLOGY
    
    J.E. Brown et al., "Coping with metastatic melanoma: The last year of life", PSYCHO-ONC, 9(4), 2000, pp. 283-292
14. Brown, JE; King, MT; Butow, PN; Dunn, SM; Coates, AS
    Patterns over time in quality of life, coping and psychological adjustmentin late stage melanoma patients: An application of multilevel models
    QUALITY OF LIFE RESEARCH
    
    J.E. Brown et al., "Patterns over time in quality of life, coping and psychological adjustmentin late stage melanoma patients: An application of multilevel models", QUAL LIFE R, 9(1), 2000, pp. 75-85
15. Castiglione-Gertsch, M; Gelber, RD; O'Neill, A; Coates, AS; Goldhirsch, A
    Systemic adjuvant treatment for premenopausal node-negative breast cancer
    EUROPEAN JOURNAL OF CANCER
    
    M. Castiglione-Gertsch et al., "Systemic adjuvant treatment for premenopausal node-negative breast cancer", EUR J CANC, 36(4), 2000, pp. 549-550
16. Butow, PN; Coates, AS; Dunn, SM
    Psychosocial predictors of survival: Metastatic breast cancer
    ANNALS OF ONCOLOGY
    
    P.N. Butow et al., "Psychosocial predictors of survival: Metastatic breast cancer", ANN ONCOL, 11(4), 2000, pp. 469-474
17. Crivellari, D; Bonetti, M; Castiglione-Gertsch, M; Gelber, RD; Rudenstam, CM; Thurlimann, B; Price, KN; Coates, AS; Hurny, C; Bernhard, J; Lindtner, J; Collins, J; Senn, HJ; Cavalli, F; Forbes, J; Gudgeon, A; Simoncini, E; Cortes-Funes, H; Veronesi, A; Fey, M; Goldhirsch, A
    Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII
    JOURNAL OF CLINICAL ONCOLOGY
    
    D. Crivellari et al., "Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII", J CL ONCOL, 18(7), 2000, pp. 1412-1422
18. Colleoni, M; Bonetti, M; Coates, AS; Castiglione-Gertsch, M; Gelber, RD; Price, K; Rudenstam, CM; Lindtner, J; Collins, J; Thurlimann, B; Holmberg, S; Veronesi, A; Marini, G; Goldhirsch, A
    Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors
    JOURNAL OF CLINICAL ONCOLOGY
    
    M. Colleoni et al., "Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors", J CL ONCOL, 18(3), 2000, pp. 584-590
19. Colleoni, M; O'Neill, A; Goldhirsch, A; Gelber, RD; Bonetti, M; Thurlimann, B; Price, KN; Castiglione-Gertsch, M; Coates, AS; Lindtner, J; Collins, J; Senn, HJ; Cavalli, F; Forbes, J; Gudgeon, A; Simoncini, E; Cortes-Funes, H; Veronesi, A; Fey, M; Rudenstam, CM
    Identifying breast cancer patients at high risk for bone metastases
    JOURNAL OF CLINICAL ONCOLOGY
    
    M. Colleoni et al., "Identifying breast cancer patients at high risk for bone metastases", J CL ONCOL, 18(23), 2000, pp. 3925-3935
20. Coates, AS; Hurny, C; Peterson, HF; Bernhard, J; Castiglione-Gertsch, M; Gelber, RD; Goldhirsch, A
    Quality-of-life scores predict outcome in metastatic but not early breast cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    A.S. Coates et al., "Quality-of-life scores predict outcome in metastatic but not early breast cancer", J CL ONCOL, 18(22), 2000, pp. 3768-3774
21. Aebi, S; Gelber, S; Castiglione-Gertsch, M; Coates, AS; Goldhirsch, A
    False negatives in oestrogen-receptor assay - Reply
    LANCET
    
    S. Aebi et al., "False negatives in oestrogen-receptor assay - Reply", LANCET, 356(9233), 2000, pp. 944-945
22. Goldhirsch, A; Francis, P; Castiglione-Gertsch, M; Gelber, RD; Coates, AS
    Taxanes as adjuvant for breast cancer
    LANCET
    
    A. Goldhirsch et al., "Taxanes as adjuvant for breast cancer", LANCET, 356(9228), 2000, pp. 507-508
23. Aebi, S; Gelber, S; Castiglione-Gertsch, M; Gelber, RD; Collins, J; Thurlimann, B; Rudenstam, CM; Lindtner, J; Crivellari, D; Cortes-Funes, H; Simoncini, E; Werner, ID; Coates, AS; Goldhirsch, A
    Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
    LANCET
    
    S. Aebi et al., "Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?", LANCET, 355(9218), 2000, pp. 1869-1874
24. Brown, JE; Butow, PN; Culjak, G; Coates, AS; Dunn, SM
    Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma
    BRITISH JOURNAL OF CANCER
    
    J.E. Brown et al., "Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma", BR J CANC, 83(11), 2000, pp. 1448-1453
25. Butow, PN; Coates, AS; Dunn, SM
    Psychosocial predictors of survival in metastatic melanoma
    JOURNAL OF CLINICAL ONCOLOGY
    
    P.N. Butow et al., "Psychosocial predictors of survival in metastatic melanoma", J CL ONCOL, 17(7), 1999, pp. 2256-2263
26. Colleoni, M; Price, KN; Castiglione-Gertsch, M; Gelber, RD; Coates, AS; Goldhirsch, A
    Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil
    LANCET
    
    M. Colleoni et al., "Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil", LANCET, 354(9173), 1999, pp. 130-131
27. Coates, AS
    Breast cancer: delays, dilemmas, and delusions
    LANCET
    
    A.S. Coates, "Breast cancer: delays, dilemmas, and delusions", LANCET, 353(9159), 1999, pp. 1112-1113
28. GOLDHIRSCH A; COATES AS; CASTIGLIONEGERTSCH M; GELBER RD
    NEW TREATMENTS FOR BREAST-CANCER - BREAKTHROUGHS FOR PATIENT-CARE OR JUST STEPS IN THE RIGHT DIRECTION
    Annals of oncology
    
    A. Goldhirsch et al., "NEW TREATMENTS FOR BREAST-CANCER - BREAKTHROUGHS FOR PATIENT-CARE OR JUST STEPS IN THE RIGHT DIRECTION", Annals of oncology, 9(9), 1998, pp. 973-976
29. GOLDHIRSCH A; COLLEONI M; COATES AS; CASTIGLIONEGERTSCH M; GELBER RD
    ADDING ADJUVANT CMF CHEMOTHERAPY TO EITHER RADIOTHERAPY OR TAMOXIFEN - ARE ALL CMFS ALIKE
    Annals of oncology
    
    A. Goldhirsch et al., "ADDING ADJUVANT CMF CHEMOTHERAPY TO EITHER RADIOTHERAPY OR TAMOXIFEN - ARE ALL CMFS ALIKE", Annals of oncology, 9(5), 1998, pp. 489-493
30. VIJUK G; COATES AS
    SURVIVAL OF PATIENTS WITH VISCERAL METASTATIC MELANOMA FROM AN OCCULTPRIMARY LESION - A RETROSPECTIVE MATCHED COHORT STUDY
    Annals of oncology
    
    G. Vijuk e A.S. Coates, "SURVIVAL OF PATIENTS WITH VISCERAL METASTATIC MELANOMA FROM AN OCCULTPRIMARY LESION - A RETROSPECTIVE MATCHED COHORT STUDY", Annals of oncology, 9(4), 1998, pp. 419-422
31. ELLIS PM; COATES AS
    ETHICS OF RANDOMIZED CLINICAL-TRIALS
    Journal of clinical oncology
    
    P.M. Ellis e A.S. Coates, "ETHICS OF RANDOMIZED CLINICAL-TRIALS", Journal of clinical oncology, 16(7), 1998, pp. 2570-2570
32. FALKSON CI; IBRAHIM J; KIRKWOOD JM; COATES AS; ATKINS MB; BLUM RH
    PHASE-III TRIAL OF DACARBAZINE VERSUS DACARBAZINE WITH INTERFERON-ALPHA-2B VERSUS DACARBAZINE WITH TAMOXIFEN VERSUS DACARBAZINE WITH INTERFERON-ALPHA-2B AND TAMOXIFEN IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY
    Journal of clinical oncology
    
    C.I. Falkson et al., "PHASE-III TRIAL OF DACARBAZINE VERSUS DACARBAZINE WITH INTERFERON-ALPHA-2B VERSUS DACARBAZINE WITH TAMOXIFEN VERSUS DACARBAZINE WITH INTERFERON-ALPHA-2B AND TAMOXIFEN IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY", Journal of clinical oncology, 16(5), 1998, pp. 1743-1751
33. GOLDHIRSCH A; COATES AS; COLLEONI M; CASTIGLIONEGERTSCH M; GELBER RD
    ADJUVANT CHEMOENDOCRINE THERAPY IN POSTMENOPAUSAL BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL DOSE AND SCHEDULE MAY MAKE A DIFFERENCE
    Journal of clinical oncology
    
    A. Goldhirsch et al., "ADJUVANT CHEMOENDOCRINE THERAPY IN POSTMENOPAUSAL BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL DOSE AND SCHEDULE MAY MAKE A DIFFERENCE", Journal of clinical oncology, 16(4), 1998, pp. 1358-1362
34. BERNHARD J; CELLA DF; COATES AS; FALLOWFIELD L; GANZ PA; MOINPOUR CM; MOSCONI P; OSOBA D; SIMES J; HURNY C
    MISSING QUALITY-OF-LIFE DATA IN CANCER CLINICAL-TRIALS - SERIOUS PROBLEMS AND CHALLENGES
    Statistics in medicine
    
    J. Bernhard et al., "MISSING QUALITY-OF-LIFE DATA IN CANCER CLINICAL-TRIALS - SERIOUS PROBLEMS AND CHALLENGES", Statistics in medicine, 17(5-7), 1998, pp. 517-532
35. BERNHARD J; PETERSON HF; COATES AS; GUSSET H; ISLEY M; HINKLE R; GELBER RD; CASTIGLIONEGERTSCH M; HURNY C
    QUALITY-OF-LIFE ASSESSMENT IN INTERNATIONAL BREAST-CANCER STUDY-GROUP(IBCSG) TRIALS - PRACTICAL ISSUES AND FACTORS ASSOCIATED WITH MISSINGDATA
    Statistics in medicine
    
    J. Bernhard et al., "QUALITY-OF-LIFE ASSESSMENT IN INTERNATIONAL BREAST-CANCER STUDY-GROUP(IBCSG) TRIALS - PRACTICAL ISSUES AND FACTORS ASSOCIATED WITH MISSINGDATA", Statistics in medicine, 17(5-7), 1998, pp. 587-601
36. COATES AS; GELBER RD; GOLDHIRSCH A
    SUBSETS WITHIN THE CHEMOTHERAPY OVERVIEW
    Lancet
    
    A.S. Coates et al., "SUBSETS WITHIN THE CHEMOTHERAPY OVERVIEW", Lancet, 352(9142), 1998, pp. 1783-1784
37. GOLDHIRSCH A; COATES AS; COLLEONI M; GELBER RD
    RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER
    The New England journal of medicine
    
    A. Goldhirsch et al., "RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER", The New England journal of medicine, 338(5), 1998, pp. 330-331
38. COATES AS
    CANCER CONTROL IN AUSTRALIA
    Medical journal of Australia
    
    A.S. Coates, "CANCER CONTROL IN AUSTRALIA", Medical journal of Australia, 169(1), 1998, pp. 8-9
39. Oakley, SP; Garsia, RJ; Coates, AS
    Eosinophilic leukaemoid reaction and interleukin-5 in metastatic melanoma
    MEDICAL JOURNAL OF AUSTRALIA
    
    S.P. Oakley et al., "Eosinophilic leukaemoid reaction and interleukin-5 in metastatic melanoma", MED J AUST, 169(9), 1998, pp. 501-501
40. QUINN MJ; CROTTY KA; THOMPSON JF; COATES AS; OBRIEN CJ; MCCARTHY WH
    DESMOPLASTIC AND DESMOPLASTIC NEUROTROPIC MELANOMA - EXPERIENCE WITH 280 PATIENTS
    Cancer
    
    M.J. Quinn et al., "DESMOPLASTIC AND DESMOPLASTIC NEUROTROPIC MELANOMA - EXPERIENCE WITH 280 PATIENTS", Cancer, 83(6), 1998, pp. 1128-1135
41. BERNHARD J; HURNY C; COATES AS; PETERSON HF; CASTIGLIONEGERTSCH M; GELBER RD; GALLIGIONI E; MARINI G; THURLIMANN B; FORBES JF; GOLDHIRSCH A; SENN HJ; RUDENSTAM CM
    FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS
    British Journal of Cancer
    
    J. Bernhard et al., "FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS", British Journal of Cancer, 78(5), 1998, pp. 686-693
42. BERNHARD J; HURNY C; PETERSON HF; GELBER RD; CASTIGLIONEGERTSCH M; COATES AS
    QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER
    Quality of life research
    
    J. Bernhard et al., "QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER", Quality of life research, 6(7-8), 1997, pp. 36-36
43. BERNHARD J; HURNY C; COATES AS; PETERSON HF; CASTIGLIONEGERTSCH M; GELBER RD; GOLDHIRSCH A; SENN HJ; RUDENSTAM CM
    QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER - THE IBCSG APPROACH
    Annals of oncology
    
    J. Bernhard et al., "QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER - THE IBCSG APPROACH", Annals of oncology, 8(9), 1997, pp. 825-835
44. BYRNE MJ; GEBSKI V; FORBES J; TATTERSALL MHN; SIMES RJ; COATES AS; DEWAR J; LUNN M; FLOWER C; GILL PG; STEWART J
    MEDROXYPROGESTERONE ACETATE ADDITION OR SUBSTITUTION FOR TAMOXIFEN INADVANCED TAMOXIFEN-RESISTANT BREAST-CANCER - A PHASE-III RANDOMIZED TRIAL
    Journal of clinical oncology
    
    M.J. Byrne et al., "MEDROXYPROGESTERONE ACETATE ADDITION OR SUBSTITUTION FOR TAMOXIFEN INADVANCED TAMOXIFEN-RESISTANT BREAST-CANCER - A PHASE-III RANDOMIZED TRIAL", Journal of clinical oncology, 15(9), 1997, pp. 3141-3148
45. DUNN SM; WELCH GW; BUTOW PN; COATES AS
    REFINING THE MEASUREMENT OF PSYCHOLOGICAL ADJUSTMENT IN CANCER
    Australian journal of psychology
    
    S.M. Dunn et al., "REFINING THE MEASUREMENT OF PSYCHOLOGICAL ADJUSTMENT IN CANCER", Australian journal of psychology, 49(3), 1997, pp. 144-151
46. SI Z; HERSEY P; COATES AS
    CLINICAL-RESPONSES AND LYMPHOID INFILTRATES IN METASTATIC MELANOMA FOLLOWING TREATMENT WITH INTRALESIONAL GM-CSF
    Melanoma research
    
    Z. Si et al., "CLINICAL-RESPONSES AND LYMPHOID INFILTRATES IN METASTATIC MELANOMA FOLLOWING TREATMENT WITH INTRALESIONAL GM-CSF", Melanoma research, 6(3), 1996, pp. 247-255
47. MARINI G; MURRAY S; GOLDHIRSCH A; GELBER RD; CASTIGLIONEGERTSCH M; PRICE KN; TATTERSALL MHN; RUDENSTAM CM; COLLINS J; LINDTNER J; CAVALLI F; CORTESFUNES H; GUDGEON A; FORBES JF; GALLIGIONI E; COATES AS; SENN HJ
    THE EFFECT OF ADJUVANT PREDNISONE COMBINED WITH CMF ON PATTERNS OF RELAPSE AND OCCURRENCE OF 2ND MALIGNANCIES IN PATIENTS WITH BREAST-CANCER
    Annals of oncology
    
    G. Marini et al., "THE EFFECT OF ADJUVANT PREDNISONE COMBINED WITH CMF ON PATTERNS OF RELAPSE AND OCCURRENCE OF 2ND MALIGNANCIES IN PATIENTS WITH BREAST-CANCER", Annals of oncology, 7(3), 1996, pp. 245-250
48. GRIFFIN AM; BUTOW PN; COATES AS; CHILDS AM; ELLIS PM; DUNN SM; TATTERSALL MHN
    ON THE RECEIVING END .5. PATIENT PERCEPTIONS OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY IN 1993
    Annals of oncology
    
    A.M. Griffin et al., "ON THE RECEIVING END .5. PATIENT PERCEPTIONS OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY IN 1993", Annals of oncology, 7(2), 1996, pp. 189-195
49. QUINN MJ; THOMPSON JE; CROTTY K; MCCARTHY WH; COATES AS
    SUBUNGUAL MELANOMA OF THE HAND
    The Journal of hand surgery
    
    M.J. Quinn et al., "SUBUNGUAL MELANOMA OF THE HAND", The Journal of hand surgery, 21A(3), 1996, pp. 506-511
50. HURNY C; BERNHARD J; COATES AS; CASTIGLIONEGERTSCH M; PETERSON HF; GELBER RD; FORBES JF; RUDENSTAM CM; SIMONCINI E; CRIVELLARI D; GOLDHIRSCH A; SENN HJ
    IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER
    Lancet
    
    C. Hurny et al., "IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER", Lancet, 347(9011), 1996, pp. 1279-1284
51. COATES AS; INGVAR CI; PETERSENSCHAEFER K; SHAW HM; MILTON GW; OBRIEN CJ; THOMPSON JF; MCCARTHY WH
    UNTITLED
    Journal of the American College of Surgeons
    
    A.S. Coates et al., "UNTITLED", Journal of the American College of Surgeons, 181(6), 1995, pp. 582-583
52. COATES AS; INGVAR CI; PETERSENSCHAEFER K; SHAW HM; MILTON GW; OBRIEN CJ; THOMPSON JF; MCCARTHY WH
    ELECTIVE LYMPH-NODE DISSECTION IN PATIENTS WITH PRIMARY MELANOMA OF THE TRUNK AND LIMBS TREATED AT THE SYDNEY MELANOMA UNIT FROM 1960 TO 1991
    Journal of the American College of Surgeons
    
    A.S. Coates et al., "ELECTIVE LYMPH-NODE DISSECTION IN PATIENTS WITH PRIMARY MELANOMA OF THE TRUNK AND LIMBS TREATED AT THE SYDNEY MELANOMA UNIT FROM 1960 TO 1991", Journal of the American College of Surgeons, 180(4), 1995, pp. 402-409
53. OBRIEN CJ; PETERSENSCHAEFER K; RUARK D; COATES AS; MENZIE SJ; HARRISON RI
    RADICAL, MODIFIED AND SELECTIVE NECK DISSECTION - FOR CUTANEOUS MALIGNANT-MELANOMA
    Head & neck
    
    C.J. Obrien et al., "RADICAL, MODIFIED AND SELECTIVE NECK DISSECTION - FOR CUTANEOUS MALIGNANT-MELANOMA", Head & neck, 17(3), 1995, pp. 232-241
54. CRIVELLARI D; PRICE KN; HAGEN M; GOLDHIRSCH A; GELBER RD; CASTIGLIONE M; COATES AS; RUDENSTAM CM; COLLINS J; LINDTNER J; CORTESFUNES H; GUDGEON A; SIMONCINI E; BYRNE M; SCHNURCH HG; FEY M; TATTERSALL MHN; FORBES JF; CAVALLI F; SENN HJ
    ROUTINE TESTS DURING FOLLOW-UP OF PATIENTS AFTER PRIMARY-TREATMENT FOR OPERABLE BREAST-CANCER
    Annals of oncology
    
    D. Crivellari et al., "ROUTINE TESTS DURING FOLLOW-UP OF PATIENTS AFTER PRIMARY-TREATMENT FOR OPERABLE BREAST-CANCER", Annals of oncology, 6(8), 1995, pp. 769-776
55. COATES AS; SEGELOV E
    LONG-TERM RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH VISCERAL METASTATIC MELANOMA
    Annals of oncology
    
    A.S. Coates e E. Segelov, "LONG-TERM RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH VISCERAL METASTATIC MELANOMA", Annals of oncology, 5(3), 1994, pp. 249-251
56. CHILDS AM; COATES AS; COX KM; MAINWARING PN
    SEVERE VASCULAR ADVERSE-EFFECTS WITH THROMBOCYTOPENIA AND RENAL-FAILURE FOLLOWING EMETOGENIC CHEMOTHERAPY AND ONDANSETRON
    Annals of oncology
    
    A.M. Childs et al., "SEVERE VASCULAR ADVERSE-EFFECTS WITH THROMBOCYTOPENIA AND RENAL-FAILURE FOLLOWING EMETOGENIC CHEMOTHERAPY AND ONDANSETRON", Annals of oncology, 5(1), 1994, pp. 98-98
57. GOLDHIRSCH A; GELBER RD; PRICE KN; CASTIGLIONE M; COATES AS; RUDENSTAM CM; COLLINS J; LINDTNER J; HACKING A; MARINI G; BYRNE M; CORTESFUNES H; SCHNURCH G; BRUNNER KW; TATTERSALL MHN; FORBES J; SENN HJ
    EFFECT OF SYSTEMIC ADJUVANT TREATMENT ON FIRST SITES OF BREAST-CANCERRELAPSE
    Lancet
    
    A. Goldhirsch et al., "EFFECT OF SYSTEMIC ADJUVANT TREATMENT ON FIRST SITES OF BREAST-CANCERRELAPSE", Lancet, 343(8894), 1994, pp. 377-381
58. THOMSON DB; ADENA M; MCLEOD GRC; HERSEY P; GILL PG; COATES AS; OLVER IN; KEFFORD RF; LOWENTHAL RM; BEADLE GF; WALPOLE ET; BOLAND K; KINGSTON D
    INTERFERON-ALPHA-2A DOES NOT IMPROVE RESPONSE OR SURVIVAL WHEN COMBINED WITH DACARBAZINE IN METASTATIC MALIGNANT-MELANOMA - RESULTS OF A MULTIINSTITUTIONAL AUSTRALIAN RANDOMIZED TRIAL
    Melanoma research
    
    D.B. Thomson et al., "INTERFERON-ALPHA-2A DOES NOT IMPROVE RESPONSE OR SURVIVAL WHEN COMBINED WITH DACARBAZINE IN METASTATIC MALIGNANT-MELANOMA - RESULTS OF A MULTIINSTITUTIONAL AUSTRALIAN RANDOMIZED TRIAL", Melanoma research, 3(2), 1993, pp. 133-138
59. RAGHAVAN D; COX K; PEARSON BS; COOREY GJ; ROGERS J; WATT WH; COATES AS; MCNEIL E; GRYGIEL JJ
    ORAL CYCLOPHOSPHAMIDE FOR THE MANAGEMENT OF HORMONE-REFRACTORY PROSTATE-CANCER
    British Journal of Urology
    
    D. Raghavan et al., "ORAL CYCLOPHOSPHAMIDE FOR THE MANAGEMENT OF HORMONE-REFRACTORY PROSTATE-CANCER", British Journal of Urology, 72(5), 1993, pp. 625-628
60. THOMPSON JF; MATHUR MN; COATES AS
    COMMON BILE-DUCT OBSTRUCTION DUE TO INTRALUMINAL METASTATIC MELANOMA
    Australian and New Zealand journal of surgery
    
    J.F. Thompson et al., "COMMON BILE-DUCT OBSTRUCTION DUE TO INTRALUMINAL METASTATIC MELANOMA", Australian and New Zealand journal of surgery, 63(6), 1993, pp. 502-504